• The Scientist
    CYCC came out with great data on sapacitabine for MDS. Not only does it work well, but it also an ORAL med. Wall St ignoring good data again
    6/1/12
    Reply (1)
    • John Rayhall: Looks like they are listening today. Too late to buy some?
      10/15/12